Community Research and Development Information Service - CORDIS

Search projects and results

Results 1 - 10 of 236
Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Medical Research Initiative South East
ID: 18835
Start date: 2005-10-01, End date: 2007-09-30
The Specific Support Action "Medical Research Initiative South East - MedResIn" has been set up to strengthen scientific & technological interaction and co-operation in biomedical research between the EU and South Eastern Europe, especially the Western Balkan countries.The cle...
Programme: FP6-LIFESCIHEALTH
Record Number: 78436
Last updated on: 2013-03-26
SME-led antibody glyco-engineering
ID: 37241
Start date: 2007-04-01, End date: 2010-09-30
The aim of the SAGE project is to establish an improved plant production platform for pharmaceutical glycoproteins. Plant systems are inexpensive, scalable and safe, providing unique advantages for the production of pharmaceutical proteins, including therapeutic antibodies tha...
Programme: FP6-LIFESCIHEALTH
Record Number: 86281
Last updated on: 2010-12-15
Functional analysis of evolutionarily conserved mechanisms of ageing on advanced proteome analysis
ID: 518230
Start date: 2006-03-01, End date: 2011-08-31
The aim of the proposal is to gain novel insight into molecular mechanisms of healthy ageing. Based on a proteomic analysis of ageing processes in a variety of ageing models including model organisms and model systems (e.g. human cell cultures), we will ad dress the question h...
Programme: FP6-LIFESCIHEALTH
Record Number: 78766
Last updated on: 2011-09-23
Final Report Summary - MIMOVAX (Alzheimer's disease-treatment targeting truncated Aß40/42 by active immunisation)
Alzheimer's disease (AD) is the most common form of dementia in humans and is caused by the abnormal deposition of Beta-amyloide (BA) plaques associated with extensive neuronal loss in the brain of patients. At present, no effective treatment is available to stop the progressi...
Programme: FP6-LIFESCIHEALTH
Record Number: 52985
Last updated on: 2011-11-03
Final Report Summary - PONT (Disease therapeutic targets, multidisciplinary parallel validation, accelerated drug discovery)
Genomics approaches deliver hundreds of candidate new disease drug targets in a single experiment. However, these targets are poorly characterised, particularly with respect to the medical relevance, and current drug discovery processes are not optimised to handle the huge num...
Programme: FP6-LIFESCIHEALTH
Record Number: 51683
Last updated on: 2011-04-14
Final Report Summary - PEROXISOMES (Integrated project to decipher the biological function of peroxisomes in health and disease)
Peroxisomes are single membrane-bound organelles, present in virtually all eukaryotic cells. In mammals, the size (0.2 - 1 µm), the number and protein content of peroxisomes vary strongly depending on the cell and tissue type as well as on the developmental and physiological s...
Programme: FP6-LIFESCIHEALTH
Record Number: 51814
Last updated on: 2011-04-14
Final Report Summary - SARS/FLU VACCINE (Development of a combined Influenza/SARS vaccine)
In 2002, an atypical pneumonia, characterised by progressive respiratory failure, emerged in southern China. The causative agent was rapidly identified as a new coronavirus - designated as Severe acute respiratory syndrome-associated virus SARS-CoV. The disease swept rapidly t...
Programme: FP6-LIFESCIHEALTH
Record Number: 51823
Last updated on: 2011-04-14
Final Report Summary - IPRAM (Intellectual property rights and assets management course)
The main ambitions of IPRAM was to raise awareness among life scientists and members of technology transfer offices of the commercial potential of their research and the research projects performed within their research institutes, respectively. This is to stimulate technology...
Programme: FP6-LIFESCIHEALTH
Record Number: 47354
Last updated on: 2011-04-14
Final Report Summary - OVCAD (Ovarian Cancer - Diagnosing a Silent Killer)
In Europe 63 000 ovarian cancer cases are diagnosed and 41 000 ovarian cancer patients die annually. 75 % of patients are diagnosed at advanced stages due to an asymptomatic course. 75 % of these patients die within 5 years. Treatment involves surgery followed by chemotherapy....
Programme: FP6-LIFESCIHEALTH
Record Number: 47036
Last updated on: 2011-04-14
Final Report Summary - ENRAH-SME (European Network for research on alternating hemiplegia in childhood for promoting SMEs integration)
ENRAH was a patient driven network. The motivation of the project team was the key to the success and in achieving all project goals under the tight deadlines and with insufficient project budget. The electronic on line format (required to facilitate and secure data collecti...
Programme: FP6-LIFESCIHEALTH
Record Number: 51987
Last updated on: 2011-04-14
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2018-01-20
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top